Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival
Cheraghlou S, Agogo GO, Girardi M. Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival. Journal Of The American Academy Of Dermatology 2018, 80: 979-989. PMID: 30365997, DOI: 10.1016/j.jaad.2018.10.026.Peer-Reviewed Original ResearchConceptsLong-term patient survivalImproved long-term patient survivalHigh-volume centersPatient survivalCase volumeNonmetastatic melanomasPatient outcomesTop quartileMiddle quartilesLong-term patient outcomesHigh-volume academic centersCenter case volumeFacility case volumeTreatment center characteristicsDisease-specific survivalNational Cancer DatabaseHigh-volume facilitiesCases of melanomaAcademic affiliationImproved survivalCancer careCancer DatabaseImproved outcomesUS adultsAcademic centersDisease site as a prognostic factor for mycosis fungoides: an analysis of 2428 cases from the US National Cancer Database
Su C, Tang R, Bai HX, Girardi M, Karakousis G, Zhang PJ, Xiao R, Zhang G. Disease site as a prognostic factor for mycosis fungoides: an analysis of 2428 cases from the US National Cancer Database. British Journal Of Haematology 2018, 185: 592-595. PMID: 30216417, DOI: 10.1111/bjh.15570.Peer-Reviewed Original Research